Cancer and fertility preservation: international recommendations from an expert meeting
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Cancer and fertility preservation : international recommendations from an expert meeting. / Lambertini, Matteo; Del Mastro, Lucia; Pescio, Maria C; Andersen, Claus Y; Azim, Hatem A; Peccatori, Fedro A; Costa, Mauro; Revelli, Alberto; Salvagno, Francesca; Gennari, Alessandra; Ubaldi, Filippo M; La Sala, Giovanni B; De Stefano, Cristofaro; Wallace, W Hamish; Partridge, Ann H; Anserini, Paola.
I: BMC Medicine, Bind 14, 1, 04.01.2016.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cancer and fertility preservation
T2 - international recommendations from an expert meeting
AU - Lambertini, Matteo
AU - Del Mastro, Lucia
AU - Pescio, Maria C
AU - Andersen, Claus Y
AU - Azim, Hatem A
AU - Peccatori, Fedro A
AU - Costa, Mauro
AU - Revelli, Alberto
AU - Salvagno, Francesca
AU - Gennari, Alessandra
AU - Ubaldi, Filippo M
AU - La Sala, Giovanni B
AU - De Stefano, Cristofaro
AU - Wallace, W Hamish
AU - Partridge, Ann H
AU - Anserini, Paola
PY - 2016/1/4
Y1 - 2016/1/4
N2 - In the last years, thanks to the improvement in the prognosis of cancer patients, a growing attention has been given to the fertility issues. International guidelines on fertility preservation in cancer patients recommend that physicians discuss, as early as possible, with all patients of reproductive age their risk of infertility from the disease and/or treatment and their interest in having children after cancer, and help with informed fertility preservation decisions. As recommended by the American Society of Clinical Oncology and the European Society for Medical Oncology, sperm cryopreservation and embryo/oocyte cryopreservation are standard strategies for fertility preservations in male and female patients, respectively; other strategies (e.g. pharmacological protection of the gonads and gonadal tissue cryopreservation) are considered experimental techniques. However, since then, new data have become available, and several issues in this field are still controversial and should be addressed by both patients and their treating physicians.In April 2015, physicians with expertise in the field of fertility preservation in cancer patients from several European countries were invited in Genova (Italy) to participate in a workshop on the topic of "cancer and fertility preservation". A total of ten controversial issues were discussed at the conference. Experts were asked to present an up-to-date review of the literature published on these topics and the presentation of own unpublished data was encouraged. On the basis of the data presented, as well as the expertise of the invited speakers, a total of ten recommendations were discussed and prepared with the aim to help physicians in counseling their young patients interested in fertility preservation.Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts in many areas of this field. The participation to the ongoing registries and prospective studies is crucial to acquire more robust information in order to provide evidence-based recommendations.
AB - In the last years, thanks to the improvement in the prognosis of cancer patients, a growing attention has been given to the fertility issues. International guidelines on fertility preservation in cancer patients recommend that physicians discuss, as early as possible, with all patients of reproductive age their risk of infertility from the disease and/or treatment and their interest in having children after cancer, and help with informed fertility preservation decisions. As recommended by the American Society of Clinical Oncology and the European Society for Medical Oncology, sperm cryopreservation and embryo/oocyte cryopreservation are standard strategies for fertility preservations in male and female patients, respectively; other strategies (e.g. pharmacological protection of the gonads and gonadal tissue cryopreservation) are considered experimental techniques. However, since then, new data have become available, and several issues in this field are still controversial and should be addressed by both patients and their treating physicians.In April 2015, physicians with expertise in the field of fertility preservation in cancer patients from several European countries were invited in Genova (Italy) to participate in a workshop on the topic of "cancer and fertility preservation". A total of ten controversial issues were discussed at the conference. Experts were asked to present an up-to-date review of the literature published on these topics and the presentation of own unpublished data was encouraged. On the basis of the data presented, as well as the expertise of the invited speakers, a total of ten recommendations were discussed and prepared with the aim to help physicians in counseling their young patients interested in fertility preservation.Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials on these topics, the level of evidence is not higher than 3 for most of the recommendations highlighting the need of further research efforts in many areas of this field. The participation to the ongoing registries and prospective studies is crucial to acquire more robust information in order to provide evidence-based recommendations.
KW - Adult
KW - Child
KW - Consensus Development Conferences as Topic
KW - Counseling
KW - Cryopreservation
KW - Europe
KW - Expert Testimony
KW - Female
KW - Fertility Preservation
KW - Humans
KW - Infertility
KW - Internationality
KW - Male
KW - Medical Oncology
KW - Neoplasms
KW - Practice Guidelines as Topic
KW - Pregnancy
KW - Reproductive Techniques, Assisted
KW - Survival Rate
KW - Young Adult
KW - Letter
KW - Research Support, Non-U.S. Gov't
U2 - 10.1186/s12916-015-0545-7
DO - 10.1186/s12916-015-0545-7
M3 - Journal article
C2 - 26728489
VL - 14
JO - BMC Medicine
JF - BMC Medicine
SN - 1741-7015
M1 - 1
ER -
ID: 173987714